¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed amputation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • musculocutaneous amputation
    ±Ù(À°)ÇǺÎÀý´Ü
  • oblique amputation
    ºñ½ºµëÀý´Ü, °æ»çÀý´Ü
  • osteoplastic amputation
    »À¼ºÇüÀý´Ü(¼ú), °ñ¼ºÇüÀý´Ü(¼ú)
  • periosteoplastic amputation
    »À¸·¼ºÇüÀý´Ü(¼ú), °ñ¸·¼ºÇüÀý´Ü(¼ú)
  • ray amputation
    °¡¶ô¿­Àý´Ü(¼ú)
  • root amputation
    Ä¡±ÙÀý´Ü, Ä¡¾Æ»Ñ¸®Àý´Ü
  • subperiosteal amputation
    »À¸·¹ØÀý´Ü(¼ú), °ñ¸·ÇÏÀý´Ü(¼ú)
  • mixed acid
    È¥ÇÕ»ê
  • mixed aphasia
    È¥ÇÕ¾ð¾î»ó½ÇÁõ, È¥ÇսǾîÁõ
  • mixed astigmatism
    È¥ÇÕ³­½Ã
  • mixed beam irradiation
    È¥ÇÕºû»ìÁ¶»ç, È¥ÇÕºöÁ¶»ç
  • mixed cellular cast
    È¥ÇÕ¼¼Æ÷¿øÁÖ
  • mixed chancre
    È¥Çձ˾ç
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • mixed cryoglobulinemia
    È¥ÇÕÇÑ·©±Û·ÎºÒ¸°Ç÷Áõ, È¥ÇÕÀú¿Â±Û·ÎºÒ¸°Ç÷Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed infection
    È¥ÇÕ°¨¿°
  • mixed beam irradiation
    È¥ÇÕºöÁ¶»ç
  • mixed joint
    È¥ÇÕ°üÀý
  • mixed nerve
    È¥ÇսŰæ
  • mixed pineocytoma
    È¥ÇÕ¼Ö¹æ¿ï»ùÁ¾
  • mixed psychosis
    È¥ÀçÁ¤½Åº´
  • mixed sequence
    º¹ÇÕ¿¬¼â
  • mixed spicule
    È¥ÇÕħ°ñ
  • mixed tumor
    È¥ÇÕÁ¾¾ç
  • mixed vaccine
    È¥ÇÕ¹é½Å
  • mixed germ cell tumor
    È¥ÇÕ¹è¾Æ¼¼Æ÷Á¾¾ç
  • mixed lymphocyte reaction
    ¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ
  • mixed suspended solid
    È¥ÇÕºÎÀ¯°íÇü¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amputation center
    Àý´Ü ¼¾ÅÍ.
  • amputation in contiguity
    °üÀýºÎ(μï½Ý») Àý´Ü.
  • amputation neuroma
    Àý´Ü½Å°æÁ¾(ï·Ó¨ãêÌèðþ)
  • amputation of devitalized pulp
    ½ÇȰġ¼öÀý´Ü(¹ý)(ã÷üÀöÍâÐôîÓ¨Ûö).
  • amputation of pulp
    Ä¡¼öÀý´Ü¹ý.
  • amputation stump
    À߸° ³¡, Àý´Ü ´Ü(ôîÓ¨Ó®).
  • aperiosteal amputation
    ¹«°ñ¸·Àý´Ü¼ú(¡­Ã¼´Ü¼ú).
  • galvanocaustic amputation
    Á÷·ù(Àü±â)¼ÒÀÛÀý´Ü.
  • galvanocaustic amputation
    Á÷·ù(Àü±â) ¼ÒÀÛ Àý´Ü.
  • guillotine amputation
    ±æ·Îƾ Àý´Ü.
  • hindquarter amputation
    ÈÄ»ç¹ÝºÎ Àý´Ü(¼ú), Àå°ñ º¹ºÎ°£ ÇÏÁö Àý´Ü(íóÍéÜÙÝ»Êàù»ò¶ôîÓ¨).
  • immediate amputation
    Áï½Ã Àý´Ü.
  • quadruple amputation
    »çÁö Àý´Ü(ÞÌò¶ôîÓ¨).
  • racket amputation
    ¶óÄÏÇü Àý´Ü(¡­û¡ôîÓ¨).
  • rectangular amputation
    Á÷°¢ Àý´Ü, À广°¢ Àý´Ü(íþÛ°ÊÇôîÓ¨).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardne s amputation
    Ä«¾Æµå³× Àý´Ü(¼ú).
  • central amputation
    Á᫐ Àý´Ü(ñéãýï·Ó¨), ÁßÃß(¼º) Àý´Ü, Áß¾Ó Àý´Ü(ñéäçï·Ó¨).
  • chop amputation
    Æò¸é ȯ»ó Àý´Ü(øÁØüü»ßÒôîÓ¨).
  • complete amputation
    ¿ÏÀü Àý´Ü(èÇîïôîÓ¨).
  • congenital amputation =natural a., spont an eus a.
    ¼±Ãµ¼º Àý´Ü(à»ô¸àõôîÓ¨), ÀÚ¿¬ Àý´Ü(í»æÔôîÓ¨).
  • cutaneous amputation
    ÇǺÎÀý´Ü(¡­ôîÓ¨).
  • diaclastic amputation
    ÆÄ°ñ Àý´Ü(÷òÍéôîÓ¨).
  • double-flap amputation
    ÀÌÁßÇÇºÎÆÇÀý´Ü.
  • double-flap amputation
    ÀÌÁß ÇÇºÎÆÇ Àý´Ü(ì£ñìù«Ý±÷ûï·Ó¨).
  • dry amputation
    °Ç¼º Àý´Ü¼ú(Ëëàõï·Ó¨âú), ¹«Ç÷Àû Àý´Ü, ¹«Ç÷¼º Àý´Ü¼ú(Ùíúìàõï·Ó¨âú).
  • elliptic amputation
    Ÿ¿øÇü Àý´Ü(¡­ôîÓ¨).
  • flap amputation
    ÇÇ(ºÎ)ÆÇ Àý´Ü(ù«Ý±÷ûôîÓ¨).
  • flapless amputation
    ¹«ÇÇ(ºÎ)ÆÇ Àý´Ü(Ùíù«Ý±÷ûôîÓ¨).
  • forequarter amputation
    °ß°© Èä°û°£ »óÁö Àý´Ü(Ì·Ë£ýØü©Êàß¾ò¶ôîÓ¨), Àü»ç¹ÝºÎ Àý´Ü, Àü4ºÐÁö 1 Àý´Ü¼ú .
  • galvanocaustic amputation
    Á÷·ù(Àü±â)¼ÒÀÛÀý´Ü.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed vaccine
    È¥¼º(ûèà÷)¹é½Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
A/E above elbow [amputation]
A/K, ak above knee [amputation]
AKA above-knee amputation; alcoholic ketoacidosis; also known as; antikeratin antibody
AK amp above-knee amputation
AMP accelerated mental processes; acid mucopolysaccharide; adenosine monophosphate; amphetamine; ampicil...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MMMT Malignant Mixed Mesodermal Tumor
MMMT Malignant mixed Mullerian tumor
MAR Mixed Anti-Globulin Reaction
MC Mixed Cellularity
M.C.T.D. Mixed Connective Tissue Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute mixed-lineage leukmia£¨±Þ¼º È¥ÇÕ-Á÷°è¼º ¹éÇ÷º´£©

    acute monocytic leukemia

    ±Þ¼º ´Ü±¸ ¹éÇ÷º´, ±Þ¼º ´Ü±¸¼º ¹éÇ÷º´
    ±Þ¼º ¹éÇ÷º´ÀÇ ÀÏÁ¾À̰í À¯¾à´Ü±¸°¡ ¹éÇ÷º´È­ÇÑ °ÍÀÌ´Ù. °ñ¼ö¿¡¼­ °ú¸³±¸°èÀÇ À¯¾à¼¼Æ÷¿Í ´Ü±¸°èÀÇ À¯¾à¼¼Æ÷°¡ È¥ÀçÇÏ´Â ¼ö°¡ ÀÖ°í ÀÌ °æ¿ì¿¡´Â ±Þ¼º °ñ¼ö´Ü±¸¼º ¹éÇ÷º´À̶ó°í ÇÑ´Ù.
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • essential mixed cryoglobulinemia
    ¿ø¹ß¼º È¥ÇÕ ÇѳÃ-±Û·Îºí¸°Áõ
    µå¹® Àü½Å¼º ÁúȯÀ¸·Î¼­ IgG-IgM º¹ÇÕü°¡ ÁÖ ¼ººÐÀÎ ÇѳÃ-±Û·Îºí¸°ÀÇ Ä§ÂøÀ¸·Î ÇǺΠÇ÷°ü¿°, Ȱ¸·¿° ¹× ÃÊÁ¡¼º ³»Áö ¹Ì¸¸¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ ³ªÅ¸³­´Ù. CÇü °£¿°°ú °°Àº °¨¿°¿¡ ¼Ó¹ßÇÏ´Â ÇѳÃ-±Û·Îºí¸°Ç÷Áõ¿¡¼­´Â ¸·Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ °üÂûµÇ±âµµ ÇÑ´Ù.
  • miscible : susceptible of being mixed.

    misdiagnosis

    ¿ÀÁø
  • mixed
    È¥ÇÕÇü, È¥ÇÕÇÑ, È¥¼ºÀÇ
  • mixed color
    È¥ÇÕ »ö
  • mixed cryoglobulin syndrome
    È¥ÇÕ Çѳà ±Û·ÎºÒ¸° ÁõÈıº
  • mixed deafness
    È¥ÇÕ¼º ³­Ã»
  • mixed dental arch
    È¥ÇÕ Ä¡¿­±Ã
  • mixed dentition analysis
    È¥ÇÕ Ä¡¿­±âÀÇ ¾Ç±Ã °ø°£ ºÐ¼®
    È¥ÇÕ Ä¡¿­±â ±³ÇÕÀº ¿µ±¸ Á¦1 ´ë±¸Ä¡°¡ ¸ÍÃâÇÏ´Â 6-7¼¼ºÎÅÍ Çü¼ºµÈ´Ù. ½ÃÁø ¹× ±¸°­ ¹æ»ç¼±ÇÐÀû °Ë»çÀÇ È°¿ëÀ» ÅëÇØ ¿µ±¸Ä¡ ¸ÍÃâ ¼ø¼­¸¦ »ìÆìº¸´Â °ÍÀº Á¤»ó ±³ÇÕ Çü¼ºÀÇ °¡´É¼º ÆÇ´Ü¿¡ À¯È¿ÇÑ Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù.
  • mixed echo
    È¥ÇÕ ¿¡ÄÚ, È¥ÇÕ ¸Þ¾Æ¸®
  • mixed form
    È¥ÇÕ Çü
  • mixed function oxidase
    È¥ÇÕ ±â´É ¿Á½Ãµ¥À̽º
  • mixed germ cell tumors
    È¥ÇÕ ¹è¾Æ¼¼Æ÷ Á¾¾ç
  • mixed headache
    È¥ÇÕÇü µÎÅë
    ±Ù ±äÀ强 µÎÅë°ú ÆíµÎÅëÀÌ ÇÑ È¯ÀÚ¿¡¼­ ÇÔ²² ³ªÅ¸³¯ ¶§.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
mixed expired gas <physiology> One or more complete breaths of expired gas coming thoroughly mixed from the dead space and the alveoli.
(05 Mar 2000)
mixed function oxidases <enzyme> Catalyse the insertion of one oxygen atom of molecular oxygen into the organ substrate. Require a second substrate to donate electrons for the reduction of the second atom in the oxygen molecule to water.
Registry number: EC 1.13.12.
(12 Dec 1998)
mixed gland A gland that contains both serous and mucous secretory units, a gland that is both exocrine and endocrine, e.g., the pancreas.
(05 Mar 2000)
mixed glioma <tumour> A glioma comprised of two or more malignant elements, most frequently astrocytoma and oligodendroglioma.
(05 Mar 2000)
mixed hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
mixed hyperlipidemia mixed hyperlipoproteinaemia familial, type 5 hyperlipidemia
mixed hyperlipoproteinaemia familial Type 5 hyperlipidemia, elevations of VLDL and chylomicrons found in plasma.
Synonym: mixed hyperlipidemia.
(05 Mar 2000)
mixed hypoglycaemia Hypoglycaemia due to more than one cause.
(05 Mar 2000)
mixed infection Infection by more than one variety of pathogenic microorganisms.
(05 Mar 2000)
mixed lymphocyte culture <investigation> Test to determine whether a patients and donor's white blood cells interact adversely. Often used to determine whether a person would be a suitable bone marrow donor for a particular patient.
(16 Dec 1997)
mixed lymphocyte culture test Measure of histocompatibility at the hl-a locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way mlc test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin c or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
(12 Dec 1998)
mixed lymphocyte reaction <haematology, immunology, investigation> Reaction of mitogenesis produced in T lymphocytes when allogeneic (i.e. Mixed) lymphocytes are brought together, provided they are mismatched in histocompatibility loci. Once used as a test for possible graft compatibility in human grafting. Now known that a negative reaction is a poor predictor of graft acceptance.
(18 Nov 1997)
mixed mesodermal tumour A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells.
Synonym: malignant mixed mullerian tumour.
(05 Mar 2000)
mixed nerve <anatomy, nerve> A nerve containing both afferent and efferent fibres.
(05 Mar 2000)
mixed opioid agonist-antagonist <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
(13 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed market economy
    È¥ÇÕ ½ÃÀå °æÁ¦
  • mixed marriage
    (´Ù¸¥ Á¾Á·,Á¾±³°£ÀÇ) ÀâÈ¥
  • mixed media
    È¥ÇÕ ¸Åü;¿µ»ó;±×¸²;À½¾Ç µîÀÇ Á¾ÇÕÀû ¿¹¼ú Ç¥Çö
  • mixed metaphor
    È¥À¯
  • mixed number
    ´ëºÐ¼ö
  • mixed tithe
    (°¡Ãà·ù¿¡¼­ÀÇ ¼öÀÍ¿¡ ´ëÇÑ) 10ºÐÀÇ 1ÀÇ ¼¼
  • mixed train
    (°´Â÷¿Í È­Â÷ÀÇ) È¥¼º ¿­Â÷
  • ready-mixed
    ¹Ì¸® Á¶Á¦(Á¶ÇÕ,È¥ÇÕ)ÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á